Efficacy and safety of rivaroxaban in cerebral venous thrombosis: insights from a prospective cohort study.

Pan, Liqun; Wang, Mengqi; Zhou, Da; Ding, Yuchuan; Ji, Xunming; Meng, Ran

Pan, Liqun; Wang, Mengqi; Zhou, Da; Ding, Yuchuan; Ji, Xunming; Meng, Ran.

Affiliation

Pan L; Department of Neurology, Xuanwu Hospital, Capital Medical University, 100053, Beijing, China.
Wang M; Advanced Center of Stroke, Beijing Institute for Brain Disorders, 100053, Beijing, China.
Zhou D; National Center for Neurological Disorders, Beijing, China.
Ding Y; Department of Neurology, Xuanwu Hospital, Capital Medical University, 100053, Beijing, China.
Ji X; Advanced Center of Stroke, Beijing Institute for Brain Disorders, 100053, Beijing, China.
Meng R; National Center for Neurological Disorders, Beijing, China.

J Thromb Thrombolysis ; 53(3): 594-600, 2022 Apr.

Article in En | MEDLINE | ID: mdl-34731403

Subject(s)

Intracranial Thrombosis; Venous Thrombosis; Anticoagulants/adverse effects; Hemorrhage/chemically induced; Hemorrhage/drug therapy; Humans; Intracranial Thrombosis/drug therapy; Prospective Studies; Retrospective Studies; Rivaroxaban/adverse effects; Treatment Outcome; Venous Thrombosis/chemically induced; Venous Thrombosis/drug therapy; Warfarin/adverse effects

Key words

Cerebral venous thrombosis; Rivaroxaban; Safety; Treatment efficacy; Warfarin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Venous Thrombosis / Intracranial Thrombosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google